EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
Year: 2010
Type: article
Source: Annals of the Rheumatic Diseases
Authors: Josef S Smolen, Robert Landewé, Ferdinand C Breedveld, Maxime Dougados, Paul Emery, Cecile Gaujoux-Viala, Simone Gorter, Rachel Knevel, Jackie Nam, Monika Schoels, Daniel Aletaha, Maya Buch, Laure Gossec, Tom Huizinga, Johannes W J W Bijlsma, Gerd Burmester, Bernard Combe, Maurizio Cutolo, Cem Gabay, Juan Gomez-Reino, Marios Kouloumas, Tore K Kvien, Emilio Martin-Mola, Iain McInnes, Karel Pavelka, Piet van Riel, Marieke Scholte, David L Scott, Tuulikki Sokka, Guido Valesini, Ronald van Vollenhoven, Kevin L Winthrop, John Wong, Angela Zink, Désirée van der Heijde
Institutions: Medical University of Vienna, Maastricht University Medical Centre, Leiden University Medical Center, Hôpital Cochin, Université Paris Descartes, University of Leeds, Pitié-Salpêtrière Hospital, Université Pierre-et-Marie-Curie, Klinik Hietzing, University Medical Center Utrecht, Humboldt-Universität zu Berlin, Charité – Universitätsmedizin Berlin, Hôpital Lapeyronie, University of Genoa, University Hospital of Geneva, Universidade de Santiago de Compostela, Complejo Hospitalario Universitario de Santiago, European League Against Rheumatism, Diakonhjemmet Hospital, Hospital Universitario La Paz, University of Glasgow, Charles University, Institute of Rheumatology, Radboud University Medical Center, King's College London, Central Finland Health Care District, Sapienza University of Rome, Karolinska University Hospital, Karolinska Institutet, Oregon Health & Science University, Tufts University, German Rheumatism Research Centre
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2607079988